Literature DB >> 30945452

Converting tests of fundamental social, cognitive, and affective processes into clinically useful bio-behavioral markers for neurodevelopmental conditions.

Eva Loth1, David W Evans2.   

Abstract

Biomarker discovery has become a central topic in neurodevelopmental research. A validated biomarker could be any objective measure or test that has clinical utility for diagnostic, stratification, or predictive purposes, or that can be used to objectively measure therapeutic efficacy. Here we discuss the potential and challenges of converting tests of fundamental social, cognitive, emotional and motivational processes into clinically useful bio-behavioral markers for neurodevelopmental conditions. Given the broad clinical and etiological heterogeneity of many neurodevelopmental conditions, we propose moving the focus from identifying group-defining characteristics to creating cross-domain bio-behavioral profiles at the individual level. We outline steps to develop tests that reflect the relevant domains and that are comparable, engaging and sensitive across large age and ability ranges. Analytical validation of these tests requires creating age norms, and optimizing psychometric properties. Individual bio-behavioral fingerprints of strengths and difficulties across domains can then be combined with multivariate approaches to identify "subgroups." This may help researchers and clinicians to compare individuals with and without intellectual disability, track developmental stability versus changes, and facilitate family genetic studies. Clinical validation requires including these tests in multidisciplinary, longitudinal and/ or intervention studies to ascertain whether particular subgroups differ in terms of their etiology, clinical symptom profile, prognosis or therapeutic benefit. Potential advantages of bio-behavioral tests over other biomarker methodologies, such as neuroimaging measures, include the low cost, ease of administration and analysis, low risk, and scalability through on-line assessments or tablet applications. This article is categorized under: Neuroscience > Development Psychology > Theory and Methods Neuroscience > Clinical Neuroscience Neuroscience > Cognition.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  autism; biomarker; cognition; neurodevelopmental disorders

Year:  2019        PMID: 30945452     DOI: 10.1002/wcs.1499

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Cogn Sci        ISSN: 1939-5078


  4 in total

1.  Neuroligins in neurodevelopmental conditions: how mouse models of de novo mutations can help us link synaptic function to social behavior.

Authors:  Tobias T Pohl; Hanna Hörnberg
Journal:  Neuronal Signal       Date:  2022-05-10

Review 2.  Are There Any Biomarkers for Pedophilia and Sexual Child Abuse? A Review.

Authors:  Kirsten Jordan; Tamara Sheila Nadine Wild; Peter Fromberger; Isabel Müller; Jürgen Leo Müller
Journal:  Front Psychiatry       Date:  2020-01-21       Impact factor: 4.157

3.  ASD-Time for a paradigm shift.

Authors:  Yonata Levy
Journal:  Front Psychiatry       Date:  2022-07-22       Impact factor: 5.435

4.  Cognitive Structure of College Students and Teaching Strategies of Ideological and Political Education Under Educational Psychology.

Authors:  Jing Zhao
Journal:  Front Psychol       Date:  2022-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.